Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 128 citing articles:

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
Wen Zhang, Huishan Wang, Mingyang Sun, et al.
Cancer Communications (2020) Vol. 40, Iss. 2-3, pp. 69-80
Open Access | Times Cited: 170
New insights into the correlations between circulating tumor cells and target organ metastasis
Qinru Zhan, Bixia Liu, Xiaohua Situ, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3
Qiong Wang, Bisheng Cheng, Sandeep Singh, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 17
Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
Milad Ashrafizadeh, Mohammad Reza Bakhoda, Zahra Bahmanpour, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 90
S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer
Si Li, Jun Zhang, Senmi Qian, et al.
Cancer Communications (2021) Vol. 41, Iss. 2, pp. 154-170
Open Access | Times Cited: 68
COL1A1: A novel oncogenic gene and therapeutic target in malignancies
Xue Li, Xiaodong Sun, Chengxia Kan, et al.
Pathology - Research and Practice (2022) Vol. 236, pp. 154013-154013
Closed Access | Times Cited: 64
Mechanisms, Diagnosis and Treatment of Bone Metastases
Jozef Ban, Valerie Fock, Dave N.T. Aryee, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2944-2944
Open Access | Times Cited: 63
Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
Feikai Lin, Xiaoduan Li, Xinjing Wang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 61
Remodelling of the tumour microenvironment by the kallikrein-related peptidases
Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 223-238
Closed Access | Times Cited: 59
Advanced applications of strontium-containing biomaterials in bone tissue engineering
Xiao Min Sheng, Chen Li, Zhonghan Wang, et al.
Materials Today Bio (2023) Vol. 20, pp. 100636-100636
Open Access | Times Cited: 40
The role of integrin family in bone metabolism and tumor bone metastasis
Liwei Mao, Lian Wang, Jiake Xu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 31
ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
Shiyong Xin, Xiang Liu, Ziyao Li, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 23
The RANKL-RANK Axis: A Bone to Thymus Round Trip
Cristina Sobacchi, Ciro Menale, Anna Villa
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 59
Salvage therapy for prostate cancer after radical prostatectomy
Nicholas G. Zaorsky, Jérémie Calais, Stefano Fanti, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 11, pp. 643-668
Closed Access | Times Cited: 42
Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers
Die Qian, Lisha He, Qing Zhang, et al.
Current Oncology (2022) Vol. 29, Iss. 8, pp. 5963-5987
Open Access | Times Cited: 32
Research progress of bone metastases: From disease recognition to clinical practice
Wenbo Yang, Qing Pan, Fuhua Huang, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 21
Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
Guoqiang Liu, Minggang Zhu, Mingrui Zhang, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1287-1287
Open Access | Times Cited: 21
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges
Carlo Sorrentino, Emma Di Carlo
Cancers (2023) Vol. 15, Iss. 11, pp. 2885-2885
Open Access | Times Cited: 17
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Small extracellular vesicles deliver osteolytic effectors and mediate cancer‐induced osteolysis in bone metastatic niche
Qinyu Ma, Mengmeng Liang, Yutong Wu, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 4
Open Access | Times Cited: 40
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer
Nathalie Bock, Thomas Kryza, Ali Shokoohmand, et al.
Science Advances (2021) Vol. 7, Iss. 27
Open Access | Times Cited: 33
Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis
Suwen Bai, Zunyun Wang, Minghua Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 25
Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis
Chiwei Chen, Shengqi Wang, Neng Wang, et al.
Phytomedicine (2023) Vol. 120, pp. 155076-155076
Closed Access | Times Cited: 13
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression
Massar Alsamraae, Diane Costanzo-Garvey, Benjamin A. Teply, et al.
Cancer Letters (2023) Vol. 579, pp. 216468-216468
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top